Most Recent
Australian law firm Mills Oakley has established an IP practice in its Melbourne office, snatching a senior lawyer from rival K&L Gates, which is now set to lose five IP specialists in the space of almost two months.
Crown Resorts has appealed a ruling in a shareholder class action against it allowing 18 former employees, who were jailed as part of the Chinese government's crackdown on gambling, to answer questions about its business in China.
Accounting giant PricewaterhouseCoopers is resisting a notice to produce audit files in a consolidated shareholder class action over the collapse of education and training company Vocation, arguing its partners face a real risk of criminal and civil penalty proceedings and are entited to claim privilege against self-incrimination.
A court has dismissed a long-running case against defunct Babcock & Brown executives by a private investment fund over a botched $1.4B acquisition of the biggest laundry equipment provider in the US, saying the executives did not breach their duties by failing to disclose that the bank underwriting the deal allegedly wanted out.
Lawyers for a shareholder class action against Crown Resorts have won their hard-fought battle to question ex-employees about the casino giant's thwarted business in China, with a judge ruling Wednesday there would likely be a "serious adverse effect" on the administration of justice if they weren't free to give evidence ahead of trial.
Two Grocon units have successfully struck out portions of an affidavit by the general counsel of property management firm Dexus Property Group, claiming prejudice in a dispute over $43.2 million in allegedly unpaid debts.
Drug maker Janssen will drop its long-running patent lawsuit against Alphapharm after the generic drug maker agreed to refrain from making products that allegedly infringe Janssen's patents for its HIV drug Prezista.
A judge has refused to contemplate delays to the long-running investor class action against defunct engineering and construction company Forge Group, as lawyers for some of the respondents warn of a “real risk” that the current trial date might need to be vacated.
After losing its fight for a temporary injunction, Sanofi-Aventis has dropped its patent lawsuit against Alphapharm over the generic drug maker's plans to market a competing insulin injector pen in Australia.
Ticket reseller Viagogo will face penalties after the court found it duped customers into thinking it was an official ticket vendor and failed to disclose booking fees of around 28 per cent, causing some customers to pay hundreds of dollars more than what their tickets were actually worth.